drugset / Trial / NCT01364259

A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia

NCT01364259

Phase 3 Terminated 17 enrolled Stanford University
RandomizedParallel-groupSingle-blindTreatment

Summary

Trigeminal neuralgia or tic douloureux is severe, often debilitating, facial pain that significantly impairs the patient's quality of life and health. Stereotactic radiosurgery has been shown to provide pain relief in majority of patients treated. However, a common side effect of radiosurgery is facial numbness. Our goal is to maximize pain control while minimizing side effects. To this end, the purpose of this study is to evaluate whether adding a drug, amifostine, at the time of radiosurgery will protect patients from facial numbness.

Timeline

Start
2008-09
Primary completion
2014-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject amifostine Unknown 500 mg Subcutaneous

Indications